(NASDAQ: TEM, “Tempus”) today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY, “BMS”), under which BMS ...
Once an afterthought, air barriers are now essential in ensuring energy efficiency, moisture management, and occupant comfort ...
The disruption of sleeping and waking patterns from the daylight saving clock change reveals a great deal about our everyday ...
Adults and adolescents with eosinophilic esophagitis (EoE) treated once-monthly with the monoclonal antibody tezepelumab ...
Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of ...
Press Trust of India on MSN
BMS seeks PM's intervention for appointment of regular CMD of BSNL
New Delhi, Oct 7 (PTI) The Bharatiya Mazdoor Sangh (BMS) on Wednesday wrote to Prime Minister Narendra Modi seeking his "urgent" intervention for the appointment of a regular CMD of BSNL and an end to ...
IHI, in partnership with Bristol Myers Squibb (BMS), is launching a new Cancer Collective Action Collaborative.
BioNTech enters a clinical trial collaboration with Gilead Sciences with the aim of improving outcomes in patients with PD-L1 low or negative ...
Pharmaceutical Technology on MSN
US targets Chinese biotech investment, but licensing deals remain exempt
Numerous types of equity deals, including the popular NewCo model, will be impacted by the proposed rule.
Battery Technology & Industry Insights. As global demand for alternative battery technologies continues to grow, sodium-ion ...
BioNTech SE and Bristol Myers Squibb Company reported initial results from the global Phase 2 ROSETTA Lung-107 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results